Clinical Trials
3 trialsNCT04994626 2021-08-06
Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior Therapies
ChineseAMS
Phase 2 Unknown
NCT04511351 2020-08-13
Radiotherapy Combined With GDP With or Without Chidamide in Stage I/II Extranodal Nasal NK/T-cell Lymphoma
ChineseAMS
Phase NA Unknown
NCT03731390 2018-11-06
GR1405 Injection in Patients With Advanced Solid Tumor or Lymphoma
ChineseAMS
Phase 1 Unknown